“Deciphera first contracted Wolfe Laboratories to conduct some analytical method development work.  We were so impressed with the quality, timeliness and dedication to the project that we began utilizing Wolfe’s DMPK services as well. They have handled our compound with confidence and it ultimately advanced into animal studies.  Throughout our partnership, the reports have been outstanding and their employees are very responsive to our needs. We will continue partnering with Wolfe Laboratories to carry more candidates through our pipeline.

- Mike Rafferty
Chief Operating Officer, Deciphera Pharmaceuticals

“We have a long-standing partnership with Wolfe Laboratories in our drug development process.  When we were faced with very aggressive timelines to acquire additional stability data, Wolfe Laboratories became an extension of Stryker’s formulation team. The communication, flexibility, experience and commitment to excellence we saw from Wolfe Laboratories during this crucial time was beyond our expectation.”

- Bret Shirley, Ph.D.
Director of Pharmaceutical Science, Stryker Biotech